Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 12

1.

Biomarkers for Infection in Children: Current Clinical Practice and Future Perspectives.

Stol K, Nijman RG, van Herk W, van Rossum AMC.

Pediatr Infect Dis J. 2019 Jun;38(6S Suppl 1):S7-S13. doi: 10.1097/INF.0000000000002318.

PMID:
31205237
2.

Herpes simplex transmission to chest and face through autoinoculation in an infant.

van Vonderen JJ, Stol K, Buddingh EP, van der Kaay DC.

BMJ Case Rep. 2017 Aug 21;2017. pii: bcr-2017-220447. doi: 10.1136/bcr-2017-220447.

PMID:
28827297
3.

Resistance to complement-mediated killing and IgM binding to non-typeable Haemophilus influenzae is not altered when ascending from the nasopharynx to the middle ears in children with otitis media.

Langereis JD, van Dongen TM, Stol K, Venekamp RP, Schilder AG, Hermans PW.

Med Microbiol Immunol. 2013 Dec;202(6):407-15. doi: 10.1007/s00430-013-0302-5. Epub 2013 Jun 18.

PMID:
23775521
4.

Microbial profiling does not differentiate between childhood recurrent acute otitis media and chronic otitis media with effusion.

Stol K, Verhaegh SJ, Graamans K, Engel JA, Sturm PD, Melchers WJ, Meis JF, Warris A, Hays JP, Hermans PW.

Int J Pediatr Otorhinolaryngol. 2013 Apr;77(4):488-93. doi: 10.1016/j.ijporl.2012.12.016. Epub 2013 Jan 29.

5.

Modified lipooligosaccharide structure protects nontypeable Haemophilus influenzae from IgM-mediated complement killing in experimental otitis media.

Langereis JD, Stol K, Schweda EK, Twelkmeyer B, Bootsma HJ, de Vries SP, Burghout P, Diavatopoulos DA, Hermans PW.

MBio. 2012 Jul 3;3(4):e00079-12. doi: 10.1128/mBio.00079-12. Print 2012.

6.

Inflammation in the middle ear of children with recurrent or chronic otitis media is associated with bacterial load.

Stol K, Diavatopoulos DA, Graamans K, Engel JA, Melchers WJ, Savelkoul HF, Hays JP, Warris A, Hermans PW.

Pediatr Infect Dis J. 2012 Nov;31(11):1128-34. doi: 10.1097/INF.0b013e3182611d6b.

PMID:
22668804
7.

Comparative analysis of the humoral immune response to Moraxella catarrhalis and Streptococcus pneumoniae surface antigens in children suffering from recurrent acute otitis media and chronic otitis media with effusion.

Verhaegh SJ, Stol K, de Vogel CP, Riesbeck K, Lafontaine ER, Murphy TF, van Belkum A, Hermans PW, Hays JP.

Clin Vaccine Immunol. 2012 Jun;19(6):914-8. doi: 10.1128/CVI.05630-11. Epub 2012 Apr 25.

8.

Two DHH subfamily 1 proteins contribute to pneumococcal virulence and confer protection against pneumococcal disease.

Cron LE, Stol K, Burghout P, van Selm S, Simonetti ER, Bootsma HJ, Hermans PW.

Infect Immun. 2011 Sep;79(9):3697-710. doi: 10.1128/IAI.01383-10. Epub 2011 Jul 18. Erratum in: Infect Immun. 2012 Aug;80(8):2974.

9.

Comparative analysis and supragenome modeling of twelve Moraxella catarrhalis clinical isolates.

Davie JJ, Earl J, de Vries SP, Ahmed A, Hu FZ, Bootsma HJ, Stol K, Hermans PW, Wadowsky RM, Ehrlich GD, Hays JP, Campagnari AA.

BMC Genomics. 2011 Jan 26;12:70. doi: 10.1186/1471-2164-12-70.

10.

The pneumococcal serine-rich repeat protein is an intra-species bacterial adhesin that promotes bacterial aggregation in vivo and in biofilms.

Sanchez CJ, Shivshankar P, Stol K, Trakhtenbroit S, Sullam PM, Sauer K, Hermans PW, Orihuela CJ.

PLoS Pathog. 2010 Aug 12;6(8):e1001044. doi: 10.1371/journal.ppat.1001044.

11.

Evaluation of drug formularies for pediatric intensive care.

Ceelie I, van der Starre C, Tibboel D, Stol K, Koren G, de Wildt SN.

Pediatr Crit Care Med. 2011 Jan;12(1):e14-9. doi: 10.1097/PCC.0b013e3181d90228.

PMID:
20228690
12.

Development of a non-invasive murine infection model for acute otitis media.

Stol K, van Selm S, van den Berg S, Bootsma HJ, Blokx WA, Graamans K, Tonnaer EL, Hermans PW.

Microbiology. 2009 Dec;155(Pt 12):4135-44. doi: 10.1099/mic.0.033175-0. Epub 2009 Sep 17.

PMID:
19762437

Supplemental Content

Support Center